Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries

ConclusionThis guideline was developed to provide an approach to the diagnosis of XLH, especially where there is no family history of the disease, and that other related conditions are not mistaken for XLH. We also guide the medical management of XLH with conventional treatment and with burosumab, a recombinant human IgG1 monoclonal antibody to FGF23.
Source: Archives of Orthopaedic and Trauma Surgery - Category: Orthopaedics Source Type: research